Clinical Trial Update: Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1 [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating domatinostat in combination with avelumab in patients with advanced Merkel cell carcinoma who progressed on anti-PD-(L)1 therapy has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Drugs mentioned

• Avelumab (avelumab)
• Domatinostat (domatinostat)

Snippet

Sponsor: 4SC AG | Conditions: Merkel Cell Carcinoma | Phase 2 | Status: COMPLETED